InvestorsHub Logo
Followers 30
Posts 5248
Boards Moderated 0
Alias Born 10/16/2012

Re: Protector post# 108205

Thursday, 01/17/2013 11:17:31 AM

Thursday, January 17, 2013 11:17:31 AM

Post# of 346000
Correct. The concern is not about getting a positive deal to move PPS. If Bavi is relevant, that will happen. The concern is more about lack of business savvy. Afterall, we are talking about someone who is more lab-oriented than business-oriented in King's case. Lytle's contract history can be of concern as well. The best case scenario is for them to get plenty of outside advice in the matter. Most times, the business talent of a $40 Billion pharmaceutical outweighs that of one that is $250 Million.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News